3 reports

Two out of the six were considered possibly related to study drug: one in Group ## and one in Group ##.

  • Antifungal
  • Infectious Disease
  • Pharmaceutical
  • Therapy
  • SCYNEXIS, Inc.

Subjects orally took study drug once daily in the evening for one month.

  • Eye Disease
  • Gene Therapy
  • Ophthalmology
  • United States
  • Product Initiative

(allergy and autoimmune diagnostics) which was sold to Thermo Fisher Scientific (TMO) in September of 2011.

  • Eye Disease
  • Gene Therapy
  • Ophthalmology
  • Pharmaceutical
  • Therapy